The implementation status and policy analysis of the"Dual-channel"management for drugs in national medical insurance negotiations
10.3969/j.issn.1674-2982.2024.05.002
- VernacularTitle:国家医保谈判药品"双通道"管理实施现状与政策分析
- Author:
Bo PENG
1
;
Xiao-Tong JIANG
;
Xiao-Juan ZHANG
;
Yuan YE
;
Xiao-Lin CAO
;
Yang LIU
;
Ya-Zi LI
Author Information
1. 中国医学科学院医学信息研究所 北京 100020
- Keywords:
Medical insurance negotiated drugs;
Dual-channel management;
Policy comparison
- From:
Chinese Journal of Health Policy
2024;17(5):9-16
- CountryChina
- Language:Chinese
-
Abstract:
Objective:This study analyzed the provincial policy on the"dual channel"management of drugs,provided suggestions for improving the"dual channel"management models.Methods:From May 10,2021 to April 10,2024,the official websites of the Healthcare Security Administration and the Health Commission of various provinces were searched for policy documents related to the"dual channel"management,and the text data were statistically analyzed.Results:The"dual-channel"management policies of various provinces coexisted with commonalities and differences.Conclusions:It is recommended to refine the access standards of the drug catalog,standardize the setting of the entry threshold of pharmaceutical institutions,scientifically determine the level of medical insurance treatment,and formulate differentiated drug identification and management methods,so as to further weaken the policy restrictive factors.
